Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYH6 MYH7 MYH9 MYH11 DYNC1H1	2.39e-05	118	97	6	GO:0003774
GeneOntologyMolecularFunction	microfilament motor activity	MYH6 MYH7 MYH9 MYH11	3.40e-05	38	97	4	GO:0000146
GeneOntologyBiologicalProcess	hindgut morphogenesis	TCF7L2 GLI2 GLI3	8.56e-06	9	98	3	GO:0007442
GeneOntologyBiologicalProcess	endocrine system development	PCSK1 TCF7L2 PDPK1 HIPK2 FOXA2 GLI2 PAX6	1.18e-05	161	98	7	GO:0035270
GeneOntologyBiologicalProcess	hindgut development	TCF7L2 GLI2 GLI3	1.22e-05	10	98	3	GO:0061525
GeneOntologyBiologicalProcess	animal organ morphogenesis	MYH6 MYH7 TCF7L2 ESR2 NACA HIPK2 MMP20 FOXA2 ANKH CRX TGFBR3 CSF3R PTPRM SULF1 GLI2 GLI3 PAX6 MMP16	2.64e-05	1269	98	18	GO:0009887
GeneOntologyBiologicalProcess	circulatory system development	STARD13 MYH6 MYH7 MYH9 MYH11 TCF7L2 PDPK1 NTRK3 NACA HIPK2 MMP21 TGFBR3 PTPRM NFE2 SULF1 GLI2 GLI3 SMG9 PAX6	4.20e-05	1442	98	19	GO:0072359
GeneOntologyBiologicalProcess	neuron fate specification	NTRK3 FOXA2 GLI2 GLI3	4.67e-05	42	98	4	GO:0048665
GeneOntologyBiologicalProcess	pituitary gland development	PCSK1 TCF7L2 GLI2 PAX6	6.15e-05	45	98	4	GO:0021983
GeneOntologyBiologicalProcess	neural tube patterning	FOXA2 GLI2 GLI3 PAX6	6.15e-05	45	98	4	GO:0021532
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in ventral spinal cord interneuron specification	GLI2 GLI3	6.68e-05	3	98	2	GO:0021775
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	GLI2 GLI3	6.68e-05	3	98	2	GO:0021776
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in ventral spinal cord patterning	GLI2 GLI3	6.68e-05	3	98	2	GO:0021910
GeneOntologyBiologicalProcess	neuron fate commitment	NTRK3 FOXA2 GLI2 GLI3 PAX6	7.35e-05	91	98	5	GO:0048663
GeneOntologyBiologicalProcess	odontogenesis	TCF7L2 MMP20 ANKH CSF3R GLI2 GLI3	8.43e-05	151	98	6	GO:0042476
GeneOntologyBiologicalProcess	pancreas development	PCSK1 TCF7L2 PDPK1 FOXA2 PAX6	1.26e-04	102	98	5	GO:0031016
GeneOntologyBiologicalProcess	odontogenesis of dentin-containing tooth	TCF7L2 MMP20 CSF3R GLI2 GLI3	1.58e-04	107	98	5	GO:0042475
GeneOntologyBiologicalProcess	dorsal/ventral neural tube patterning	FOXA2 GLI2 GLI3	2.22e-04	25	98	3	GO:0021904
GeneOntologyBiologicalProcess	negative regulation of fibroblast growth factor receptor signaling pathway	TCF7L2 SHISA2 SULF1	2.80e-04	27	98	3	GO:0040037
GeneOntologyBiologicalProcess	cell fate specification	NTRK3 FOXA2 GLI2 GLI3 PAX6	3.03e-04	123	98	5	GO:0001708
GeneOntologyBiologicalProcess	cellular response to fibroblast growth factor stimulus	TCF7L2 SHISA2 SULF1 PAX6 CEP57	3.15e-04	124	98	5	GO:0044344
GeneOntologyBiologicalProcess	chordate embryonic development	MYH6 MYH9 TCF7L2 CPT2 FOXA2 TGFBR3 NFE2 SULF1 GLI2 GLI3 SMG9 PAX6 MMP16	3.53e-04	906	98	13	GO:0043009
GeneOntologyBiologicalProcess	response to fibroblast growth factor	TCF7L2 SHISA2 SULF1 PAX6 CEP57	4.20e-04	132	98	5	GO:0071774
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	MYH6 MYH9 TCF7L2 CPT2 FOXA2 TGFBR3 NFE2 SULF1 GLI2 GLI3 SMG9 PAX6 MMP16	4.47e-04	929	98	13	GO:0009792
GeneOntologyBiologicalProcess	forebrain dorsal/ventral pattern formation	GLI3 PAX6	4.62e-04	7	98	2	GO:0021798
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	GLI2 GLI3	4.62e-04	7	98	2	GO:0060831
GeneOntologyBiologicalProcess	prostate gland epithelium morphogenesis	ESR2 SULF1 GLI2	5.12e-04	33	98	3	GO:0060740
GeneOntologyBiologicalProcess	in utero embryonic development	MYH6 MYH9 TCF7L2 CPT2 FOXA2 TGFBR3 NFE2 GLI2 GLI3 SMG9	5.38e-04	596	98	10	GO:0001701
GeneOntologyBiologicalProcess	prostate gland morphogenesis	ESR2 SULF1 GLI2	5.59e-04	34	98	3	GO:0060512
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	STARD13 MYH6 MYH7 MYH9 MYH11 PDPK1 HIPK2 MMP20 FOXA2 TGFBR3 CSF3R PTPRM NFE2 SULF1 GLI2 GLI3 PAX6	5.81e-04	1483	98	17	GO:0048646
GeneOntologyBiologicalProcess	embryonic digestive tract development	TCF7L2 GLI2 GLI3	6.10e-04	35	98	3	GO:0048566
GeneOntologyBiologicalProcess	insulin metabolic process	PCSK1 TCF7L2 PAX6	6.10e-04	35	98	3	GO:1901142
GeneOntologyBiologicalProcess	cell fate specification involved in pattern specification	GLI2 GLI3	6.14e-04	8	98	2	GO:0060573
GeneOntologyBiologicalProcess	ventral spinal cord interneuron specification	GLI2 GLI3	6.14e-04	8	98	2	GO:0021521
GeneOntologyCellularComponent	myosin filament	MYH6 MYH7 MYH9 MYH11	5.55e-06	25	99	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH6 MYH7 MYH9 MYH11	8.88e-06	28	99	4	GO:0016460
GeneOntologyCellularComponent	muscle myosin complex	MYH6 MYH7 MYH11	5.52e-05	16	99	3	GO:0005859
GeneOntologyCellularComponent	GLI-SUFU complex	GLI2 GLI3	1.32e-04	4	99	2	GO:1990788
GeneOntologyCellularComponent	myosin complex	MYH6 MYH7 MYH9 MYH11	1.76e-04	59	99	4	GO:0016459
MousePheno	abnormal axial skeleton morphology	DCAF15 TCF7L2 PTBP2 PDPK1 HIPK2 MMP21 CPT2 MMP20 FOXA2 ANKH TGFBR3 NFE2 SULF1 GLI2 GLI3 PAH SMG9 PAX6 C9orf72 SLC4A4 MMP16 CEP57	3.75e-06	1458	74	22	MP:0002114
MousePheno	abnormal cranium morphology	DCAF15 TCF7L2 PTBP2 PDPK1 HIPK2 MMP21 MMP20 FOXA2 ANKH NFE2 GLI2 GLI3 SMG9 PAX6 SLC4A4 MMP16	4.13e-06	813	74	16	MP:0000438
MousePheno	abnormal craniofacial bone morphology	DCAF15 TCF7L2 PTBP2 PDPK1 HIPK2 MMP21 MMP20 FOXA2 ANKH NFE2 GLI2 GLI3 SMG9 PAX6 SLC4A4 MMP16	5.14e-06	827	74	16	MP:0002116
MousePheno	abnormal jaw morphology	DCAF15 PTBP2 PDPK1 HIPK2 MMP21 MMP20 FOXA2 ANKH GLI2 GLI3 PAX6 SLC4A4	2.00e-05	530	74	12	MP:0000454
MousePheno	abnormal forebrain morphology	TCF7L2 OPN4 HIVEP2 PTBP2 PDPK1 ESR2 HIPK2 SHISA2 FAAH GLI3 PAH ST8SIA2 SYN1 SMG9 PAX6 DYNC1H1 ALG13	3.37e-05	1072	74	17	MP:0000783
MousePheno	abnormal forelimb morphology	TCF7L2 PDPK1 ESR2 TGFBR3 GLI2 GLI3 MMP16	4.87e-05	182	74	7	MP:0000550
MousePheno	abnormal viscerocranium morphology	DCAF15 PTBP2 PDPK1 HIPK2 MMP21 MMP20 FOXA2 ANKH GLI2 GLI3 PAX6 SLC4A4	6.00e-05	593	74	12	MP:0005274
MousePheno	duplication of ductus venosus	TCF7L2 SMG9	8.27e-05	3	74	2	MP:0013879
MousePheno	basisphenoid bone foramen	TCF7L2 GLI3 SMG9	1.30e-04	19	74	3	MP:0004463
Domain	Myosin_N	MYH6 MYH7 MYH9 MYH11	9.31e-07	15	98	4	PF02736
Domain	Myosin_N	MYH6 MYH7 MYH9 MYH11	9.31e-07	15	98	4	IPR004009
Domain	Myosin_tail_1	MYH6 MYH7 MYH9 MYH11	2.06e-06	18	98	4	PF01576
Domain	Myosin_tail	MYH6 MYH7 MYH9 MYH11	2.06e-06	18	98	4	IPR002928
Domain	Myosin-like_IQ_dom	MYH6 MYH7 MYH9 MYH11	2.60e-06	19	98	4	IPR027401
Domain	-	MYH6 MYH7 MYH9 MYH11	2.60e-06	19	98	4	4.10.270.10
Domain	Myosin_head_motor_dom	MYH6 MYH7 MYH9 MYH11	4.59e-05	38	98	4	IPR001609
Domain	MYOSIN_MOTOR	MYH6 MYH7 MYH9 MYH11	4.59e-05	38	98	4	PS51456
Domain	Myosin_head	MYH6 MYH7 MYH9 MYH11	4.59e-05	38	98	4	PF00063
Domain	MYSc	MYH6 MYH7 MYH9 MYH11	4.59e-05	38	98	4	SM00242
Domain	IQ	MYH6 MYH7 MYH9 MYH11 ADGB	6.71e-05	81	98	5	SM00015
Domain	Pept_M10A_stromelysin-type	MMP21 MMP20 MMP16	1.08e-04	18	98	3	IPR016293
Domain	IQ_motif_EF-hand-BS	MYH6 MYH7 MYH9 MYH11 ADGB	1.11e-04	90	98	5	IPR000048
Domain	IQ	MYH6 MYH7 MYH9 MYH11 ADGB	1.29e-04	93	98	5	PS50096
Domain	PG_binding_1	MMP21 MMP20 MMP16	1.50e-04	20	98	3	PF01471
Domain	Peptidoglycan-bd-like	MMP21 MMP20 MMP16	1.50e-04	20	98	3	IPR002477
Domain	Hemopexin-like_dom	MMP21 MMP20 MMP16	2.30e-04	23	98	3	IPR000585
Domain	Hemopexin-like_repeat	MMP21 MMP20 MMP16	2.30e-04	23	98	3	IPR018487
Domain	M10A_MMP	MMP21 MMP20 MMP16	2.30e-04	23	98	3	IPR033739
Domain	Hemopexin	MMP21 MMP20 MMP16	2.30e-04	23	98	3	PF00045
Domain	HEMOPEXIN	MMP21 MMP20 MMP16	2.30e-04	23	98	3	PS00024
Domain	-	MMP21 MMP20 MMP16	2.30e-04	23	98	3	2.110.10.10
Domain	HEMOPEXIN_2	MMP21 MMP20 MMP16	2.30e-04	23	98	3	PS51642
Domain	HX	MMP21 MMP20 MMP16	2.30e-04	23	98	3	SM00120
Domain	Pept_M10A	MMP21 MMP20 MMP16	2.30e-04	23	98	3	IPR021190
Domain	Peptidase_M10	MMP21 MMP20 MMP16	2.62e-04	24	98	3	PF00413
Domain	HnRNP-L/PTB	PTBP3 PTBP2	2.70e-04	5	98	2	IPR006536
Domain	ZnMc	MMP21 MMP20 MMP16	4.64e-04	29	98	3	SM00235
Domain	Peptidase_Metallo	MMP21 MMP20 MMP16	4.64e-04	29	98	3	IPR006026
Domain	CYSTEINE_SWITCH	MMP21 MMP20 MMP16	1.29e-03	41	98	3	PS00546
Domain	Pept_M10_metallopeptidase	MMP21 MMP20 MMP16	1.48e-03	43	98	3	IPR001818
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DYNC1H1	2.38e-03	14	98	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DYNC1H1	2.38e-03	14	98	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DYNC1H1	2.38e-03	14	98	2	IPR013602
Domain	DHC_N2	DNAH3 DYNC1H1	2.38e-03	14	98	2	PF08393
Domain	MT	DNAH3 DYNC1H1	2.38e-03	14	98	2	PF12777
Domain	AAA_8	DNAH3 DYNC1H1	2.38e-03	14	98	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DYNC1H1	2.38e-03	14	98	2	IPR011704
Domain	AAA_5	DNAH3 DYNC1H1	2.38e-03	14	98	2	PF07728
Domain	DHC_fam	DNAH3 DYNC1H1	2.74e-03	15	98	2	IPR026983
Domain	CysPc	CAPN13 ADGB	2.74e-03	15	98	2	SM00230
Domain	Pept_M10A_Zn_BS	MMP20 MMP16	2.74e-03	15	98	2	IPR021158
Domain	Peptidase_C2_calpain_cat	CAPN13 ADGB	2.74e-03	15	98	2	IPR001300
Domain	Peptidase_C2	CAPN13 ADGB	2.74e-03	15	98	2	PF00648
Domain	Dynein_heavy_dom	DNAH3 DYNC1H1	2.74e-03	15	98	2	IPR004273
Domain	CALPAIN_CAT	CAPN13 ADGB	2.74e-03	15	98	2	PS50203
Domain	Sialyl_trans	ST3GAL3 ST8SIA2	2.74e-03	15	98	2	IPR012163
Domain	Dynein_heavy	DNAH3 DYNC1H1	2.74e-03	15	98	2	PF03028
Domain	Glyco_trans_29	ST3GAL3 ST8SIA2	4.87e-03	20	98	2	IPR001675
Domain	Glyco_transf_29	ST3GAL3 ST8SIA2	4.87e-03	20	98	2	PF00777
Pubmed	Rab34 small GTPase is required for Hedgehog signaling and an early step of ciliary vesicle formation in mouse.	FOXA2 GLI2 GLI3 PAX6	4.29e-09	8	99	4	30301781
Pubmed	Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis.	FOXA2 GLI2 GLI3 PAX6	7.70e-09	9	99	4	37943875
Pubmed	The loss of Hh responsiveness by a non-ciliary Gli2 variant.	FOXA2 GLI2 GLI3 PAX6	7.70e-09	9	99	4	25834022
Pubmed	Wnt signaling inhibitors regulate the transcriptional response to morphogenetic Shh-Gli signaling in the neural tube.	TCF7L2 GLI2 GLI3 PAX6	7.70e-09	9	99	4	16950124
Pubmed	Gli1 can rescue the in vivo function of Gli2.	FOXA2 GLI2 GLI3 PAX6	1.28e-08	10	99	4	11748151
Pubmed	Suppressor of Fused Chaperones Gli Proteins To Generate Transcriptional Responses to Sonic Hedgehog Signaling.	FOXA2 GLI2 GLI3 PAX6	1.28e-08	10	99	4	27849569
Pubmed	Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia.	FOXA2 GLI2 GLI3 PAX6	2.01e-08	11	99	4	30791390
Pubmed	Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins.	FOXA2 GLI2 GLI3 PAX6	2.01e-08	11	99	4	16364285
Pubmed	PKA-mediated Gli2 and Gli3 phosphorylation is inhibited by Hedgehog signaling in cilia and reduced in Talpid3 mutant.	FOXA2 GLI2 GLI3 PAX6	2.01e-08	11	99	4	28673820
Pubmed	Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus.	MYH6 MYH7 MYH11	2.24e-08	3	99	3	8620598
Pubmed	IFT25 links the signal-dependent movement of Hedgehog components to intraflagellar transport.	FOXA2 GLI2 GLI3 PAX6	3.00e-08	12	99	4	22595669
Pubmed	Dual function of suppressor of fused in Hh pathway activation and mouse spinal cord patterning.	FOXA2 GLI2 GLI3 PAX6	3.00e-08	12	99	4	22182519
Pubmed	Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord.	FOXA2 GLI2 GLI3 PAX6	3.00e-08	12	99	4	28412462
Pubmed	Increased proteolytic processing of full-length Gli2 transcription factor reduces the hedgehog pathway activity in vivo.	FOXA2 GLI2 GLI3 PAX6	3.00e-08	12	99	4	21337666
Pubmed	Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.	MYH6 MYH7 MYH9 MYH11	3.00e-08	12	99	4	8424456
Pubmed	The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis.	FOXA2 GLI2 GLI3 PAX6	3.00e-08	12	99	4	32758357
Pubmed	Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice.	FOXA2 GLI2 GLI3 PAX6	4.33e-08	13	99	4	9636069
Pubmed	Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors.	FOXA2 GLI2 GLI3 PAX6	6.05e-08	14	99	4	20463034
Pubmed	Complex interactions between genes controlling trafficking in primary cilia.	FOXA2 GLI2 GLI3 PAX6	6.05e-08	14	99	4	21552265
Pubmed	Small ubiquitin-like Modifier (SUMO) modification inhibits GLI2 protein transcriptional activity in vitro and in vivo.	FOXA2 GLI2 GLI3 PAX6	6.05e-08	14	99	4	22549777
Pubmed	Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling.	FOXA2 GLI2 GLI3 PAX6	6.05e-08	14	99	4	19666503
Pubmed	A predictive model of bifunctional transcription factor signaling during embryonic tissue patterning.	FOXA2 GLI2 GLI3 PAX6	8.23e-08	15	99	4	25458012
Pubmed	Changes in expression of nonmuscle myosin heavy chain isoforms during muscle and nonmuscle tissue development.	MYH6 MYH7 MYH9	8.93e-08	4	99	3	8482409
Pubmed	Three Tctn proteins are functionally conserved in the regulation of neural tube patterning and Gli3 processing but not ciliogenesis and Hedgehog signaling in the mouse.	FOXA2 GLI2 GLI3 PAX6	1.09e-07	16	99	4	28800946
Pubmed	Gli2 is required for induction of floor plate and adjacent cells, but not most ventral neurons in the mouse central nervous system.	FOXA2 GLI2 GLI3 PAX6	1.09e-07	16	99	4	9655799
Pubmed	Ciliary and extraciliary Gpr161 pools repress hedgehog signaling in a tissue-specific manner.	FOXA2 GLI2 GLI3 PAX6	1.09e-07	16	99	4	34346313
Pubmed	The ciliary phosphatidylinositol phosphatase Inpp5e plays positive and negative regulatory roles in Shh signaling.	FOXA2 GLI2 GLI3 PAX6	1.09e-07	16	99	4	31964774
Pubmed	A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro.	FOXA2 GLI2 GLI3	2.23e-07	5	99	3	9118802
Pubmed	Gli1 is a target of Sonic hedgehog that induces ventral neural tube development.	FOXA2 GLI2 GLI3	2.23e-07	5	99	3	9216996
Pubmed	Forward genetics uncovers Transmembrane protein 107 as a novel factor required for ciliogenesis and Sonic hedgehog signaling.	FOXA2 GLI2 GLI3 PAX6	2.32e-07	19	99	4	22698544
Pubmed	The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling.	FOXA2 GLI2 GLI3 PAX6	2.32e-07	19	99	4	23332756
Pubmed	Cell Cycle-Related Kinase (CCRK) regulates ciliogenesis and Hedgehog signaling in mice.	FOXA2 GLI2 GLI3 PAX6	2.32e-07	19	99	4	28817564
Pubmed	Loss of dynein-2 intermediate chain Wdr34 results in defects in retrograde ciliary protein trafficking and Hedgehog signaling in the mouse.	FOXA2 GLI2 GLI3 PAX6	2.89e-07	20	99	4	28379358
Pubmed	Ankmy2 Prevents Smoothened-Independent Hyperactivation of the Hedgehog Pathway via Cilia-Regulated Adenylyl Cyclase Signaling.	FOXA2 GLI2 GLI3 PAX6	2.89e-07	20	99	4	32702291
Pubmed	Disruption of Mks1 localization to the mother centriole causes cilia defects and developmental malformations in Meckel-Gruber syndrome.	FOXA2 GLI2 GLI3 PAX6	2.89e-07	20	99	4	21045211
Pubmed	Protein kinase A acts at the basal body of the primary cilium to prevent Gli2 activation and ventralization of the mouse neural tube.	FOXA2 GLI2 GLI3 PAX6	3.56e-07	21	99	4	22007132
Pubmed	Differential requirement of SUFU in tissue development discovered in a hypomorphic mouse model.	FOXA2 GLI2 GLI3 PAX6	3.56e-07	21	99	4	28688895
Pubmed	Temporal and spatial requirements of Smoothened in ventral midbrain neuronal development.	FOXA2 GLI2 GLI3 PAX6	3.56e-07	21	99	4	23618354
Pubmed	Mouse hitchhiker mutants have spina bifida, dorso-ventral patterning defects and polydactyly: identification of Tulp3 as a novel negative regulator of the Sonic hedgehog pathway.	FOXA2 GLI2 GLI3 PAX6	4.34e-07	22	99	4	19223390
Pubmed	Broad-minded links cell cycle-related kinase to cilia assembly and hedgehog signal transduction.	FOXA2 GLI2 GLI3 PAX6	4.34e-07	22	99	4	20159594
Pubmed	Tcf/Lef repressors differentially regulate Shh-Gli target gene activation thresholds to generate progenitor patterning in the developing CNS.	TCF7L2 FOXA2 GLI2 PAX6	4.34e-07	22	99	4	21775418
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	FOXA2 GLI2 GLI3 PAX6	5.25e-07	23	99	4	30814516
Pubmed	Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway.	FOXA2 GLI2 GLI3 PAX6	5.25e-07	23	99	4	16459298
Pubmed	Centrosomal protein Dzip1l binds Cby, promotes ciliary bud formation, and acts redundantly with Bromi to regulate ciliogenesis in the mouse.	FOXA2 GLI2 GLI3 PAX6	7.46e-07	25	99	4	29487109
Pubmed	Wnt signaling determines ventral spinal cord cell fates in a time-dependent manner.	FOXA2 GLI2 GLI3 PAX6	7.46e-07	25	99	4	18927156
Pubmed	Myosin regulatory light chains are required to maintain the stability of myosin II and cellular integrity.	MYH6 MYH7 MYH9	7.77e-07	7	99	3	21126233
Pubmed	Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus.	FOXA2 GLI2 GLI3	7.77e-07	7	99	3	9731531
Pubmed	Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos.	FOXA2 GLI2 GLI3 PAX6	8.80e-07	26	99	4	37228654
Pubmed	The small GTPase RSG1 controls a final step in primary cilia initiation.	FOXA2 GLI2 GLI3 PAX6	1.20e-06	28	99	4	29038301
Pubmed	Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.	FOXA2 GLI2 GLI3 PAX6	1.20e-06	28	99	4	26884322
Pubmed	Gene regulatory logic for reading the Sonic Hedgehog signaling gradient in the vertebrate neural tube.	GLI2 GLI3 PAX6	1.24e-06	8	99	3	22265416
Pubmed	Distinct effects of Hedgehog signaling on neuronal fate specification and cell cycle progression in the embryonic mouse retina.	CRX GLI2 GLI3 PAX6	1.39e-06	29	99	4	19474320
Pubmed	Intraflagellar transport protein 122 antagonizes Sonic Hedgehog signaling and controls ciliary localization of pathway components.	FOXA2 GLI2 GLI3 PAX6	1.39e-06	29	99	4	21209331
Pubmed	Pax6 is required for normal cell-cycle exit and the differentiation kinetics of retinal progenitor cells.	CRX GLI2 GLI3 PAX6	1.60e-06	30	99	4	24073291
Pubmed	Floor plate-derived sonic hedgehog regulates glial and ependymal cell fates in the developing spinal cord.	FOXA2 GLI2 GLI3 PAX6	1.60e-06	30	99	4	23482494
Pubmed	Wdpcp, a PCP protein required for ciliogenesis, regulates directional cell migration and cell polarity by direct modulation of the actin cytoskeleton.	FOXA2 GLI2 GLI3 PAX6	1.60e-06	30	99	4	24302887
Pubmed	Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.	FOXA2 GLI2 GLI3 SYN1	1.83e-06	31	99	4	22889265
Pubmed	Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation.	FOXA2 GLI2 GLI3	1.86e-06	9	99	3	10725236
Pubmed	Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway.	FOXA2 GLI2 PAX6	1.86e-06	9	99	3	12361967
Pubmed	Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.	FOXA2 GLI2 GLI3	1.86e-06	9	99	3	25083987
Pubmed	Tubby-like protein 3 (TULP3) regulates patterning in the mouse embryo through inhibition of Hedgehog signaling.	FOXA2 GLI2 GLI3 PAX6	2.09e-06	32	99	4	19286674
Pubmed	The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling.	GLI2 GLI3 PAX6	2.65e-06	10	99	3	19549984
Pubmed	Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis.	GLI2 GLI3 PAX6	2.65e-06	10	99	3	38358805
Pubmed	Patched1 patterns Fibroblast growth factor 10 and Forkhead box F1 expression during pulmonary branch formation.	FOXA2 GLI2 GLI3	2.65e-06	10	99	3	28939119
Pubmed	Gli3 utilizes Hand2 to synergistically regulate tissue-specific transcriptional networks.	MYH6 GLI2 GLI3	2.65e-06	10	99	3	33006313
Pubmed	Differential requirement for Gli2 and Gli3 in ventral neural cell fate specification.	FOXA2 GLI2 GLI3	2.65e-06	10	99	3	12812795
Pubmed	Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1.	FOXA2 GLI2 GLI3	2.65e-06	10	99	3	9247260
Pubmed	Antagonistic and cooperative actions of Kif7 and Sufu define graded intracellular Gli activities in Hedgehog signaling.	FOXA2 GLI2 PAX6	2.65e-06	10	99	3	23166838
Pubmed	Spatial pattern of sonic hedgehog signaling through Gli genes during cerebellum development.	GLI2 GLI3 PAX6	2.65e-06	10	99	3	15496441
Pubmed	Characterization of Opr deficiency in mouse brain: subtle defects in dorsomedial telencephalon and medioventral forebrain.	TCF7L2 GLI3 PAX6	2.65e-06	10	99	3	15736266
Pubmed	Complementary Gli activity mediates early patterning of the mouse visual system.	GLI2 GLI3 PAX6	3.63e-06	11	99	3	16342201
Pubmed	PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function.	FOXA2 GLI3 PAX6	3.63e-06	11	99	3	24697898
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 TCF7L2 HIVEP2 PTBP2 HIPK2 ANKMY1 FRYL ST3GAL3 ANKH BDH1 ZNF462 GLI2 PLCB4 ABLIM2 MMP16 PDZD2	4.64e-06	1489	99	16	28611215
Pubmed	Ventral neural patterning in the absence of a Shh activity gradient from the floorplate.	FOXA2 GLI3 PAX6	4.83e-06	12	99	3	28891097
Pubmed	A homeodomain feedback circuit underlies step-function interpretation of a Shh morphogen gradient during ventral neural patterning.	FOXA2 GLI3 PAX6	4.83e-06	12	99	3	21062862
Pubmed	IFT56 regulates vertebrate developmental patterning by maintaining IFTB complex integrity and ciliary microtubule architecture.	FOXA2 GLI2 PAX6	4.83e-06	12	99	3	28264835
Pubmed	T396I mutation of mouse Sufu reduces the stability and activity of Gli3 repressor.	FOXA2 GLI2 GLI3	6.27e-06	13	99	3	25760946
Pubmed	Multifaceted Functions of Rab23 on Primary Cilium-Mediated and Hedgehog Signaling-Mediated Cerebellar Granule Cell Proliferation.	GLI2 GLI3 PAX6	6.27e-06	13	99	3	34210780
Pubmed	Disruption of PAX6 function in mice homozygous for the Pax6Sey-1Neu mutation produces abnormalities in the early development and regionalization of the diencephalon.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	9232602
Pubmed	Ftm is a novel basal body protein of cilia involved in Shh signalling.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	17553904
Pubmed	Tulp3 is a critical repressor of mouse hedgehog signaling.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	19334287
Pubmed	Centrosomal protein CP110 controls maturation of the mother centriole during cilia biogenesis.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	26965371
Pubmed	Intestinal cell kinase, a protein associated with endocrine-cerebro-osteodysplasia syndrome, is a key regulator of cilia length and Hedgehog signaling.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	24853502
Pubmed	Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved.	GLI2 GLI3 PAX6	6.27e-06	13	99	3	19684112
Pubmed	Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity.	FOXA2 GLI2 GLI3	6.27e-06	13	99	3	21093585
Pubmed	The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development.	FOXA2 GLI3 PAX6	6.27e-06	13	99	3	19592253
Pubmed	Interaction between hedgehog signalling and PAX6 dosage mediates maintenance and regeneration of the corneal epithelium.	GLI2 GLI3 PAX6	6.27e-06	13	99	3	22275805
Pubmed	Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.	MYH6 MYH7 MYH9 MYH11 DYNC1H1	6.82e-06	92	99	5	37343697
Pubmed	Overlapping roles and collective requirement for the coreceptors GAS1, CDO, and BOC in SHH pathway function.	FOXA2 GLI2 PAX6	7.96e-06	14	99	3	21664576
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	8.02e-06	2	99	2	21526716
Pubmed	Neocortical origin and tangential migration of guidepost neurons in the lateral olfactory tract.	GLI3 PAX6	8.02e-06	2	99	2	10908621
Pubmed	Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2.	HIPK2 PAX6	8.02e-06	2	99	2	16407227
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	8.02e-06	2	99	2	2726733
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	8.02e-06	2	99	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	8.02e-06	2	99	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	8.02e-06	2	99	2	8307559
Pubmed	A novel protein-processing domain in Gli2 and Gli3 differentially blocks complete protein degradation by the proteasome.	GLI2 GLI3	8.02e-06	2	99	2	17283082
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	8.02e-06	2	99	2	2969919
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	8.02e-06	2	99	2	17575272
Pubmed	New mouse models of congenital anorectal malformations.	GLI2 GLI3	8.02e-06	2	99	2	10693670
Cytoband	1q44	OR2T27 OR2T7 OR2T4 OR2AJ1	9.86e-05	110	99	4	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2T27 OR2T7 OR2T4 OR2AJ1	1.77e-04	128	99	4	chr1q44
GeneFamily	Myosin heavy chains	MYH6 MYH7 MYH9 MYH11	3.05e-07	15	72	4	1098
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP21 MMP20 MMP16	1.15e-04	24	72	3	891
GeneFamily	Olfactory receptors, family 2	OR2T27 OR2T7 OR2T4 OR2AJ1	1.07e-03	113	72	4	149
GeneFamily	C2 domain containing\|Calpains	CAPN13 ADGB	1.59e-03	15	72	2	975
GeneFamily	Sialyltransferases	ST3GAL3 ST8SIA2	2.84e-03	20	72	2	438
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	SBF1 C9orf72	4.42e-03	25	72	2	504
Coexpression	GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP	IGSF8 EGLN3 HIPK2 FOXA2 PIGZ RHOF PDZD2	7.20e-06	195	95	7	M7125
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 MYH11 HIVEP2 ANKH ZNF462 PLCB4	3.31e-06	182	99	6	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE9 RBMS1 PLEKHD1 ZNF462 TGFBR3 PTPRM	3.52e-06	184	99	6	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 GLI2 GLI3 PAX6 SLC4A4 PRODH	3.87e-06	187	99	6	dd1d91f101b837bba513f77defa6e6902b2c0570
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 GLI2 GLI3 PAX6 SLC4A4 PRODH	3.87e-06	187	99	6	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 GLI2 GLI3 PAX6 SLC4A4 PRODH	3.87e-06	187	99	6	ae90c263f80c36a410150d499e268d198944a3d9
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 SULF1 GLI2 GLI3 ST8SIA2 MMP16	4.50e-06	192	99	6	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NTRK3 TGFBR3 SULF1 GLI2 GLI3 MMP16	4.92e-06	195	99	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	Substantia_nigra-Macroglia-ASTROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GLI2 GLI3 PAX6 SLC4A4 PRODH	1.24e-05	134	99	5	a632d78890fcc20db81d2cf6b299470706d2e182
ToppCell	Substantia_nigra-Macroglia-ASTROCYTE-Gja1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GLI2 GLI3 PAX6 SLC4A4 PRODH	1.24e-05	134	99	5	8be2db71d9d29f9a57a64efdc89cf8c3e32b363b
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI2 GLI3 PAX6 PRODH	2.35e-05	153	99	5	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI2 GLI3 PAX6 PRODH	2.35e-05	153	99	5	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI2 GLI3 PAX6 PRODH	2.35e-05	153	99	5	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	frontal_cortex-Non-neuronal-astrocyte-Astro\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI3 PAX6 SLC4A4 PRODH	2.67e-05	157	99	5	0551442ae14685d8fe5729e3960c6324b1e05e4d
ToppCell	frontal_cortex-Non-neuronal-astrocyte\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI3 PAX6 SLC4A4 PRODH	2.67e-05	157	99	5	803af734d7f775d294391e2b84e472a732e18cef
ToppCell	frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF7L2 GLI3 PAX6 SLC4A4 PRODH	2.67e-05	157	99	5	9aa5304a9704da6dd4eda7d6940494b00e38b2e8
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	STARD13 EGLN3 PLEKHD1 PLCB4 LILRA4	2.83e-05	159	99	5	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK1 TCF7L2 OR2T27 OR2T7 OR2T4	3.38e-05	165	99	5	ee48ca87aed7c19a26c0ae42ce6a6f51b2fe3b8b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CELF5 NTRK3 CSF3R SYN1 SEZ6L	3.38e-05	165	99	5	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8\|GI_large-bowel / Manually curated celltypes from each tissue	TCF7L2 TGFBR3 SYN1 PLCB4 PAX6	3.48e-05	166	99	5	13bef304ea3df8e8d2bc376a3287c78220a1b0c6
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLB1L CPT2 MILR1 CLCN6 PAQR3	3.68e-05	168	99	5	27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f
ToppCell	control-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	EGLN3 ESR2 CRX SBF1 DHTKD1	3.68e-05	168	99	5	affc39c7568b7df4b36af6f5b0e3702a18b6268c
ToppCell	367C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	EGLN3 SLC35G2 PLEKHD1 TGFBR3 LILRA4	3.90e-05	170	99	5	fbb7019c6fba87326702b51f6819ea1af5f3a9b7
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK1 KCNH7 FOXA2 PAX6 SEZ6L	4.47e-05	175	99	5	c031da47ca63d1133e13530cbf779df9435e22cb
ToppCell	COVID-19-kidney-REN+Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	STARD13 NTRK3 MILR1 MAP3K5 MMP16	4.98e-05	179	99	5	342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 MYH11 HIVEP2 ESR2 PLCB4	4.98e-05	179	99	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ESR2 FRYL PTPRM PLCB4 PDZD2	4.98e-05	179	99	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST3GAL3 FAAH SLC4A4 DHTKD1 PRODH	5.39e-05	182	99	5	770ce9f3f4538d0181a0181543841bc964c68274
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EGLN3 CPNE9 MILR1 PLCB4 LILRA4	5.39e-05	182	99	5	9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST3GAL3 FAAH SLC4A4 DHTKD1 PRODH	5.39e-05	182	99	5	77ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST3GAL3 FAAH SLC4A4 DHTKD1 PRODH	5.39e-05	182	99	5	4921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EGLN3 CPNE9 MILR1 PLCB4 LILRA4	5.39e-05	182	99	5	4602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell	facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESR2 MMP21 PTPRM SULF1 SLC4A4	5.53e-05	183	99	5	12e876d6205af8aad74265c668b5e95b9e7487f3
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 HIPK2 PTPRM PLCB4 HERC5	5.53e-05	183	99	5	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE9 ESR2 TGFBR3 SULF1 PLCB4	5.68e-05	184	99	5	f506d0ee48f39d6f59f19554217dfdf0987cc405
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE9 ESR2 TGFBR3 SULF1 PLCB4	5.68e-05	184	99	5	8bcb1c4bc8ffef74338cdade926a94711de93c64
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 OPN4 NTRK3 GLI2 PLCB4	5.82e-05	185	99	5	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 OPN4 NTRK3 GLI2 PLCB4	5.82e-05	185	99	5	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ESR2 TGFBR3 PTPRM PLCB4 MMP16	5.82e-05	185	99	5	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK1 PAH SYN1 ABLIM2 SEZ6L	5.98e-05	186	99	5	2fab7abed16a894afdd0207e86fc43a25a77fb9e
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	EGLN3 ESR2 PLEKHD1 PLCB4 LILRA4	5.98e-05	186	99	5	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK1 PAH SYN1 ABLIM2 SEZ6L	5.98e-05	186	99	5	ea2c8e0df038a00062d2098b4a9ac85141b9a728
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	EGLN3 ESR2 PLEKHD1 PLCB4 LILRA4	5.98e-05	186	99	5	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	EGLN3 ESR2 PLEKHD1 PLCB4 LILRA4	5.98e-05	186	99	5	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK1 PAH SYN1 ABLIM2 SEZ6L	5.98e-05	186	99	5	714765585a644bf9817ab6eb3001b43b3c2d2410
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	EGLN3 ESR2 PLEKHD1 PLCB4 LILRA4	5.98e-05	186	99	5	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EGLN3 ESR2 PLEKHD1 PLCB4 LILRA4	5.98e-05	186	99	5	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STARD13 EGLN3 HIPK2 PTPRM PLCB4	6.13e-05	187	99	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	EGLN3 ESR2 PLCB4 DHTKD1 LILRA4	6.13e-05	187	99	5	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHISA2 TGFBR3 SULF1 ABLIM2 MMP16	6.13e-05	187	99	5	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH9 SHISA2 TGFBR3 SULF1 ABLIM2	6.29e-05	188	99	5	047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYH9 MYH11 NTRK3 SULF1 PLCB4	6.44e-05	189	99	5	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	TGFBR3 SULF1 GLI2 GLI3 MMP16	6.61e-05	190	99	5	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 MAP3K5 ST8SIA2 PLCB4 MMP16	6.61e-05	190	99	5	5681c211baeed4af82a2bbc13420f6a7b487581c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 ANKH MAP3K5 SULF1 GLI2	6.77e-05	191	99	5	1caf726bd07fdca389e678fc16304a6ef1790423
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NTRK3 GLI2 GLI3 PLCB4	6.77e-05	191	99	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 ANKH MAP3K5 SULF1 GLI2	6.77e-05	191	99	5	3d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NTRK3 GLI2 GLI3 PLCB4	6.77e-05	191	99	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 ANKH MAP3K5 SULF1 GLI2	6.94e-05	192	99	5	4022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NTRK3 SULF1 GLI2 GLI3	6.94e-05	192	99	5	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 ANKH MAP3K5 SULF1 GLI2	6.94e-05	192	99	5	9333aba0d04203ccccad78d82bf6359922f810a7
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	NTRK3 SULF1 GLI2 GLI3 MMP16	6.94e-05	192	99	5	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 HIPK2 PTPRM PLCB4 MMP16	7.11e-05	193	99	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 HIPK2 PTPRM PLCB4 MMP16	7.11e-05	193	99	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	VE-pDC-\|VE / Condition, Cell_class and T cell subcluster	EGLN3 MILR1 KMO PLCB4 LILRA4	7.11e-05	193	99	5	583724de588fcde3aeda056138c522dc0225a387
ToppCell	P15-Endothelial-large_vessel_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ESR2 SULF1 PLCB4 MMP16 PDZD2	7.11e-05	193	99	5	5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5
ToppCell	VE-pDC\|VE / Condition, Cell_class and T cell subcluster	EGLN3 MILR1 KMO PLCB4 LILRA4	7.11e-05	193	99	5	bb759dc9ef0ec41d655002f59021d62d62d44289
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	RPL27 NACA PLCB4 PAX6 SEZ6L	7.47e-05	195	99	5	da8680a91648843901e456b5faef5e85039ade15
ToppCell	COVID-19-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	EGLN3 MILR1 KMO PLCB4 LILRA4	7.47e-05	195	99	5	4a7c080230ce6a79335ecbeadecb0177b2c13625
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TCF7L2 SULF1 GLI2 GLI3 SLC4A4	7.65e-05	196	99	5	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NTRK3 SULF1 GLI2 MMP16	7.65e-05	196	99	5	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NTRK3 SULF1 GLI2 MMP16	7.65e-05	196	99	5	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 MAP3K5 SULF1 GLI2 GLI3	7.84e-05	197	99	5	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC35G2 PTPRM SULF1 PLCB4 PDZD2	8.03e-05	198	99	5	58508a8df2714d769f137794c29441a7bd38b350
ToppCell	medial\|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYH9 RBMS1 HIPK2 TGFBR3 LILRA4	8.03e-05	198	99	5	071658de0c43f302172692aa0b4b507dbad7be50
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MAP3K5 GLI3 PAX6 SLC4A4 PRODH	8.41e-05	200	99	5	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EGLN3 PLEKHD1 NPFFR1 PAX6	1.31e-04	116	99	4	605bd4fdf547cc41783e99cd78425760ef6461ef
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MMP20 HARBI1 SMG9 DHTKD1	1.97e-04	129	99	4	cbeeaa554da971ba2e4c4b82c85a1d070a45abb8
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Cbln1-Gpr88_(Medial_entorrhinal_cortex)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CPNE9 ESR2 NFE2	2.63e-04	56	99	3	a310f50724ada8da92257c54b18d9214d7415010
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Cbln1-Gpr88_(Medial_entorrhinal_cortex)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CPNE9 ESR2 NFE2	2.63e-04	56	99	3	4740900fffc892200f3e2480328eb43cb6d19f20
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IGSF8 MILR1 KMO SYN1	3.32e-04	148	99	4	31a7c2b20970070b14d2b955020320a6f99db547
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SHISA2 SULF1 GLI2 SYN1	3.49e-04	150	99	4	7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SHISA2 SULF1 GLI2 SYN1	3.49e-04	150	99	4	e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee
ToppCell	LPS-IL1RA-Myeloid_granulocytic\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKH CLCN6 CSF3R SYN1	3.86e-04	154	99	4	d55fb73461885e1e02061a344ff89624ef4de487
ToppCell	LPS-IL1RA-Myeloid_granulocytic-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKH CLCN6 CSF3R SYN1	3.86e-04	154	99	4	43735f7c58cac51855ded486ee8d8729a1b9909e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 NTRK3 SLC4A4 PDZD2	4.15e-04	157	99	4	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF8 FARSA CLCN6 SULF1	4.25e-04	158	99	4	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	facs-Heart-RV-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 BDH1 CRX DHTKD1	4.25e-04	158	99	4	2ef43d14ee65d004dc62c12ff209bbe12e4db681
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PCSK1 KCNH7 PAH SEZ6L	4.35e-04	159	99	4	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	STARD13 PLEKHD1 PLCB4 LILRA4	4.35e-04	159	99	4	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC35G2 NPFFR1 PTPRM PLCB4	4.57e-04	161	99	4	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	PBMC-Severe-cDC_2\|Severe / Compartment, Disease Groups and Clusters	HARBI1 SLC4A4 ABLIM2	4.87e-04	69	99	3	0fab02d29408415d3aa1f42a55a2e37b458c4030
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SHISA2 TGFBR3 GLI3 PRODH	5.12e-04	166	99	4	f416d8a322f086c769659a9fab6b460a2d546ab1
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SHISA2 SLC35G2 ADGB ZNF462	5.12e-04	166	99	4	8d5d09f25e8903d481c2097fed435e69d42ccdb5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DNAH3 PAH SEZ6L PDZD2	5.24e-04	167	99	4	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	SHISA2 GLI3 PLCB4 PRODH	5.24e-04	167	99	4	5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e
Drug	Ioversol [87771-40-2]; Up 200; 5uM; HL60; HT_HG-U133A	EGLN3 MYH11 TCF7L2 EYA3 PTPRM SULF1 GLI2 MMP16 SEZ6L	1.83e-07	197	98	9	3026_UP
Drug	purealin	MYH6 MYH7 MYH9 MYH11 DYNC1H1	5.10e-06	58	98	5	CID006419303
Drug	carvedilol	MYH6 MYH7 MYH9 MYH11 MMP21 MMP20 MMP16	6.26e-06	161	98	7	CID000002585
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	STARD13 TCF7L2 HIVEP2 NACA FOXA2 GLI3 PAX6	1.30e-05	180	98	7	7094_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	STARD13 PTBP3 EGLN3 ANKMY1 NPFFR1 EDEM3 FARSA	2.10e-05	194	98	7	7036_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ANKH FAAH TGFBR3 CLCN6 SBF1 HERC5 PRODH	2.10e-05	194	98	7	3828_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A	PTBP3 TCF7L2 PIGZ EDEM3 SULF1 SMG9 MMP16	2.17e-05	195	98	7	5318_DN
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 HIVEP2 GLB1L PIGZ BDH1 SLC4A4 MMP16	2.17e-05	195	98	7	4557_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; HL60; HT_HG-U133A	DCAF15 ZNF609 ESR2 EYA3 ANKH SBF1 CSF3R	2.40e-05	198	98	7	2948_UP
Drug	Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A	PTBP3 DCAF15 TCF7L2 ANKMY1 NPFFR1 MMP16 PRODH	2.40e-05	198	98	7	5673_DN
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HG-U133A	PTBP3 ZNF609 CPT2 PIGZ DHTKD1 PAQR3 SEZ6L	2.40e-05	198	98	7	1962_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ZNF609 PDPK1 CPT2 FAAH DMXL1 SBF1 SMG9	2.56e-05	200	98	7	2838_DN
Drug	formycin triphosphate	MYH6 MYH7 MYH9 MYH11	6.91e-05	51	98	4	CID000122274
Drug	S-(-)-Etomoxir	MYH6 MYH7 MYH9 MYH11 CPT2	7.26e-05	100	98	5	CID000060765
Drug	pyrophosphate	MYH6 MYH7 MYH9 MYH11 PDPK1 ANKH FARSA PLCB4 QARS1 DHTKD1 CEP57	1.18e-04	654	98	11	CID000001023
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	PTBP3 GLB1L ANKMY1 CLCN6 SLC4A4 PRODH	1.59e-04	187	98	6	1662_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	STARD13 PTBP3 DNAH3 TCF7L2 SULF1 MMP16	1.59e-04	187	98	6	6948_DN
Drug	cyclosporine A; Up 200; 1uM; MCF7; HG-U133A	NTRK3 CPT2 NPFFR1 SLC4A4 RWDD2A SEZ6L	1.84e-04	192	98	6	602_UP
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A	HIVEP2 PTBP2 HIPK2 CPT2 PTPRM SLC4A4	1.89e-04	193	98	6	1961_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 TCF7L2 FARSA SULF1 MMP16 CEP57	1.89e-04	193	98	6	4846_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A	PTBP3 HIVEP2 NPFFR1 FAAH SLC4A4 MMP16	1.95e-04	194	98	6	3932_DN
Drug	oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA	STARD13 EGLN3 ZNF609 FAAH SULF1 RHOF	1.95e-04	194	98	6	971_DN
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A	PTBP3 ZNF609 TCF7L2 NPFFR1 KMO PLCB4	1.95e-04	194	98	6	2206_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A	DNAH3 ANKMY1 NPFFR1 KMO MAP3K5 SBF1	1.95e-04	194	98	6	4249_DN
Drug	Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PTBP3 ZNF609 NACA FAAH MAP3K5 EDEM3	1.95e-04	194	98	6	6767_DN
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; PC3; HT_HG-U133A	MYH7 EYA3 ADGB CLCN6 GLI2 SEZ6L	1.95e-04	194	98	6	4224_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	STARD13 TCF7L2 HIVEP2 HIPK2 MAP3K5 PDZD2	1.95e-04	194	98	6	4662_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	HIPK2 EYA3 NPFFR1 KMO ADGB NFE2	1.95e-04	194	98	6	2684_DN
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	DCAF15 EGLN3 TCF7L2 CPT2 SBF1 RWDD2A	1.95e-04	194	98	6	4721_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	HIVEP2 CPT2 DMXL1 SBF1 PDZD2 ALG13	2.00e-04	195	98	6	2104_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	DNAH3 BDH1 MAP3K5 FEZ2 SLC4A4 ALG13	2.00e-04	195	98	6	1561_DN
Drug	5-aminosalicylic acid; Up 200; 100uM; MCF7; HG-U133A	PTBP3 ZNF609 PIGZ NPFFR1 RHOF SEZ6L	2.00e-04	195	98	6	124_UP
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A	PTBP3 ZNF609 TCF7L2 CLCN6 PLCB4 RWDD2A	2.00e-04	195	98	6	3108_DN
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	STARD13 HIPK2 CLCN6 SULF1 MMP16 HERC5	2.00e-04	195	98	6	5228_DN
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A	NTRK3 EYA3 SULF1 GLI2 SEZ6L LILRA4	2.00e-04	195	98	6	3028_UP
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	RBMS1 NTRK3 NACA PIGZ RHOF SEZ6L	2.06e-04	196	98	6	610_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 DNAH3 TCF7L2 CPT2 BDH1 PRODH	2.06e-04	196	98	6	6954_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; HL60; HT_HG-U133A	STARD13 MYH11 NPFFR1 ANKH GLI3 ALG13	2.06e-04	196	98	6	2939_UP
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	ANKH KMO MAP3K5 ADGB SULF1 GLI2	2.06e-04	196	98	6	5863_UP
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	ZNF609 HIVEP2 ANKMY1 PIGZ NPFFR1 HERC5	2.06e-04	196	98	6	1511_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; HL60; HG-U133A	DNAH3 TCF7L2 DMXL1 EDEM3 SMG9 ALG13	2.06e-04	196	98	6	1775_DN
Drug	Denatonium benzoate [3734-33-6]; Up 200; 9uM; HL60; HT_HG-U133A	STARD13 DCAF15 ANKMY1 PIGZ NPFFR1 GLI3	2.06e-04	196	98	6	3123_UP
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	STARD13 PTBP3 DNAH3 MYH9 TCF7L2 PRODH	2.06e-04	196	98	6	6988_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A	ZNF609 MAP3K5 SBF1 SMG9 DHTKD1 SEZ6L	2.06e-04	196	98	6	1912_UP
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	STARD13 PTBP3 DCAF15 TCF7L2 EDEM3 SBF1	2.11e-04	197	98	6	3319_DN
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A	TCF7L2 HIVEP2 NACA NPFFR1 SBF1 ALG13	2.11e-04	197	98	6	2092_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	TCF7L2 CPT2 NPFFR1 BDH1 SULF1 GLI3	2.11e-04	197	98	6	5340_DN
Drug	1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	PTBP3 EGLN3 ZNF609 GLB1L HIPK2 PRODH	2.11e-04	197	98	6	22_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	STARD13 EGLN3 TCF7L2 FRYL MAP3K5 GLI3	2.11e-04	197	98	6	6218_DN
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A	HIPK2 KMO ADGB PTPRM PRODH PDZD2	2.11e-04	197	98	6	5529_UP
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; HL60; HT_HG-U133A	DCAF15 ZNF609 TCF7L2 HIPK2 ANKMY1 SBF1	2.11e-04	197	98	6	2909_DN
Drug	Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ZNF609 ANKMY1 SBF1 PAX6 MMP16 LILRA4	2.11e-04	197	98	6	7174_UP
Drug	Roxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A	EYA3 KMO ADGB CLCN6 SULF1 SEZ6L	2.11e-04	197	98	6	4192_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	PTBP3 ANKH MAP3K5 EDEM3 CLCN6 SLC4A4	2.11e-04	197	98	6	3797_DN
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	PTBP3 DCAF15 ANKMY1 FAAH SULF1 SLC4A4	2.11e-04	197	98	6	1507_DN
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	TCF7L2 HIPK2 NPFFR1 FAAH SULF1 PRODH	2.11e-04	197	98	6	6017_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	PTBP3 HIVEP2 ANKMY1 NPFFR1 FAAH PRODH	2.11e-04	197	98	6	5361_DN
Drug	WY-14643; Down 200; 100uM; MCF7; HG-U133A	HIPK2 NPFFR1 KMO MMP16 HERC5 SEZ6L	2.17e-04	198	98	6	368_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	DCAF15 ZNF609 NPFFR1 FAAH EDEM3 CLCN6	2.17e-04	198	98	6	2297_DN
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	PTBP3 EGLN3 TCF7L2 HIVEP2 EDEM3 SULF1	2.17e-04	198	98	6	6208_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A	DCAF15 ZNF609 TCF7L2 HIVEP2 CPT2 SBF1	2.17e-04	198	98	6	1534_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	DNAH3 ESR2 NTRK3 EYA3 NPFFR1 MMP16	2.17e-04	198	98	6	6395_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A	PTBP3 DCAF15 ZNF609 NTRK3 KMO SEZ6L	2.17e-04	198	98	6	1391_UP
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; PC3; HT_HG-U133A	MYH7 MYH11 CLCN6 SULF1 GLI2 LILRA4	2.17e-04	198	98	6	4261_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	ZNF609 GLB1L ESR2 EYA3 FAAH CLCN6	2.17e-04	198	98	6	6630_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; HL60; HG-U133A	TCF7L2 NTRK3 EDEM3 CLCN6 PAQR3 ALG13	2.17e-04	198	98	6	1975_UP
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DCAF15 ZNF609 ESR2 CLCN6 MMP16 HERC5	2.17e-04	198	98	6	5002_UP
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	PTBP3 ZNF609 ANKH KMO CLCN6 MMP16	2.17e-04	198	98	6	4434_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	ESR2 EYA3 CLCN6 SULF1 SEZ6L LILRA4	2.23e-04	199	98	6	5079_UP
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; HL60; HG-U133A	DCAF15 NTRK3 NACA SLC4A4 DHTKD1 HERC5	2.23e-04	199	98	6	1425_UP
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 ZNF609 TCF7L2 HIVEP2 PTBP2 SBF1	2.23e-04	199	98	6	1467_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	PTBP3 HIVEP2 ANKMY1 TGFBR3 SBF1 GLI3	2.23e-04	199	98	6	5542_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DNAH3 MYH9 TCF7L2 PIGZ ADO GLI3	2.23e-04	199	98	6	6214_DN
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A	ESR2 NTRK3 HIPK2 EYA3 NPFFR1 SBF1	2.29e-04	200	98	6	3398_UP
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; HL60; HG-U133A	ESR2 NTRK3 ANKMY1 NPFFR1 KMO SULF1	2.29e-04	200	98	6	1722_UP
Disease	Cardiomyopathy, Familial Idiopathic	MYH6 MYH7 TCF7L2 CPT2	1.83e-05	50	92	4	C1449563
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	5.75e-05	4	92	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	5.75e-05	4	92	2	cv:C3495498
Disease	Caveolinopathy	MYH6 MYH7	5.75e-05	4	92	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	5.75e-05	4	92	2	192600
Disease	cerebellum cortex volume change measurement, age at assessment	TCF7L2 HIVEP2 PTPRM	7.24e-05	26	92	3	EFO_0008007, EFO_0021497
Disease	phenylalanine measurement, amino acid measurement	PAH PRODH	9.56e-05	5	92	2	EFO_0005001, EFO_0005134
Disease	Paroxysmal atrial fibrillation	MYH6 MYH7 ESR2 NACA ZNF462	1.32e-04	156	92	5	C0235480
Disease	familial atrial fibrillation	MYH6 MYH7 ESR2 NACA ZNF462	1.32e-04	156	92	5	C3468561
Disease	Persistent atrial fibrillation	MYH6 MYH7 ESR2 NACA ZNF462	1.32e-04	156	92	5	C2585653
Disease	retinal disease (implicated_via_orthology)	OPN4 PLCB4	1.43e-04	6	92	2	DOID:5679 (implicated_via_orthology)
Disease	neutropenia, response to metamizole, Drug-induced agranulocytosis	STARD13 TGFBR3	1.43e-04	6	92	2	EFO_0010971, HP_0012235, MONDO_0001475
Disease	Atrial Fibrillation	MYH6 MYH7 ESR2 NACA ZNF462	1.48e-04	160	92	5	C0004238
Disease	glucose measurement	PCSK1 TCF7L2 RBMS1 FOXA2 ANKH EDEM3 GLI3	1.90e-04	380	92	7	EFO_0004468
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	2.00e-04	7	92	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	2.00e-04	7	92	2	C0597124
Disease	Cataract	MYH9 PAX6 SLC4A4	2.11e-04	37	92	3	C0086543
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	3.41e-04	9	92	2	C0949658
Disease	primary bacterial infectious disease (implicated_via_orthology)	GLI2 GLI3	3.41e-04	9	92	2	DOID:0050338 (implicated_via_orthology)
Disease	Odontome	ANKH PAX6	4.26e-04	10	92	2	C0524730
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0080719 (implicated_via_orthology)
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	4.26e-04	10	92	2	cv:C5675009
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:3429 (implicated_via_orthology)
Disease	Tooth Abnormalities	ANKH PAX6	4.26e-04	10	92	2	C0040427
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	4.26e-04	10	92	2	DOID:0080326 (implicated_via_orthology)
Disease	Gastrointestinal Stromal Sarcoma	HIPK2 GLI2 GLI3	4.31e-04	47	92	3	C3179349
Disease	Schizophrenia	TCF7L2 ESR2 NTRK3 KMO PAH ST8SIA2 SYN1 PAX6 C9orf72 PRODH	4.31e-04	883	92	10	C0036341
Disease	Cardiomyopathy, Dilated	MYH6 MYH7 TCF7L2	4.58e-04	48	92	3	C0007193
Disease	Gastrointestinal Stromal Tumors	HIPK2 GLI2 GLI3	5.17e-04	50	92	3	C0238198
Disease	cognitive decline measurement, memory performance, language measurement	MYH9 GLI3	5.19e-04	11	92	2	EFO_0004874, EFO_0007710, EFO_0007797
Disease	body mass index, fasting blood glucose measurement	PCSK1 TCF7L2 FOXA2	5.48e-04	51	92	3	EFO_0004340, EFO_0004465
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7	6.22e-04	12	92	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7	6.22e-04	12	92	2	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	7.33e-04	13	92	2	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7	9.83e-04	15	92	2	DOID:0050646 (implicated_via_orthology)
Disease	atrial fibrillation	MYH6 MYH7 MYH11 ESR2 NACA ZNF462	1.09e-03	371	92	6	EFO_0000275
Disease	cathepsin L1 measurement	ADGB C9orf72	1.12e-03	16	92	2	EFO_0010619
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 KMO PRODH	1.27e-03	68	92	3	DOID:5419 (implicated_via_orthology)
Disease	noggin measurement	HIVEP2 NFE2	1.42e-03	18	92	2	EFO_0021995
Disease	Endometrioma	ESR2 NTRK3 ANKH HERC5	1.64e-03	161	92	4	C0269102
Disease	Endometriosis	ESR2 NTRK3 ANKH HERC5	1.64e-03	161	92	4	C0014175
Disease	Disproportionate short stature	ANKH SULF1 GLI3	1.82e-03	77	92	3	C0878659
Disease	hypothyroidism (biomarker_via_orthology)	PCSK1 MYH6 MYH7	2.03e-03	80	92	3	DOID:1459 (biomarker_via_orthology)
Disease	Primary familial hypertrophic cardiomyopathy	MYH6 MYH7	2.13e-03	22	92	2	cv:C0949658
Disease	BMI-adjusted fasting blood glucose measurement	TCF7L2 FOXA2	2.33e-03	23	92	2	EFO_0008036
Disease	Coronary heart disease	TCF7L2 ESR2	2.54e-03	24	92	2	C0010068
Disease	Pseudoaphakia	PAX6 SLC4A4	2.54e-03	24	92	2	C0524524
Disease	Lens Opacities	PAX6 SLC4A4	2.54e-03	24	92	2	C1510497
Disease	Hypertrophic obstructive cardiomyopathy	MYH6 MYH7	2.75e-03	25	92	2	C4551472
Disease	inflammatory bowel disease (implicated_via_orthology)	ESR2 PDZD2	2.75e-03	25	92	2	DOID:0050589 (implicated_via_orthology)
Disease	Intellectual Disability	HIVEP2 ST3GAL3 ZNF462 PAX6 DYNC1H1 ALG13	2.78e-03	447	92	6	C3714756
Disease	visual epilepsy (biomarker_via_orthology)	PCSK1 ANKH MAP3K5	2.83e-03	90	92	3	DOID:11832 (biomarker_via_orthology)
Disease	total blood protein measurement	DNAH3 ZNF609 TCF7L2 MAP3K5 ADO FEZ2	2.85e-03	449	92	6	EFO_0004536
Disease	Limb-girdle muscular dystrophy	MYH6 MYH7	2.98e-03	26	92	2	cv:C0686353

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSSSVPHGAVYYPVM	ALG13	1056	Q9NP73
LTATTPYTRYHPMDY	BDH1	306	Q02338
QTSHMVVYATFTPLY	ADGB	411	Q8N7X0
NLPPVTYMHIYETDG	ADO	81	Q96SZ5
GSMVRHSSSPYVVYP	CEP57	26	Q86XR8
DRPDMISYSPYISHS	ABLIM2	326	Q6H8Q1
TMTYHLSPGNYVVVA	CAPN13	446	Q6MZZ7
TVNMFVVHPTTPAQY	DHTKD1	731	Q96HY7
NVRRMTSHPTLPYYL	DMXL1	2746	Q9Y485
SNRPSYYMFPTLLQH	FAM200A	391	Q8TCP9
HEVQPSYATRYAMTV	EGLN3	196	Q9H6Z9
PGQYLQRSIVPTMHY	CPT2	31	P23786
YLPQYAHMQTTAVPV	RBMS1	366	P29558
MYSAKPYAHILSVPV	EYA3	71	Q99504
PPHIFSISDNAYQYM	MYH7	151	P12883
STVYVMQYRHSKPCP	PAQR3	291	Q6TCH7
VSPLLHTPMYYFLSS	OR8D1	51	Q8WZ84
YQHTSPVAAMFIVAY	NPFFR1	36	Q9GZQ6
GRSYDTYTPPHMQTH	PAX6	366	P26367
SDHSKYMPDLTPQYV	NOL9	436	Q5SY16
YQAEFPMSPVTSAHA	LILRA4	376	P59901
GVSPAEYYHQMALLT	GLI3	231	P10071
YITPTMAQAPYSFPH	HIPK2	1061	Q9H2X6
HEYPAMTFYSPAVMN	ESR2	41	Q92731
GMSNASVALTVYYPP	NTRK3	291	Q16288
VVPPAYSMVTAGSEY	KCNH7	1066	Q9NS40
NTHYDAIMRYISQPP	EDEM3	316	Q9BZQ6
PETPAEYRYNMAHSA	HARBI1	241	Q96MB7
LPHTYRTGSIMQPNY	MMP21	291	Q8N119
AAIYTYMLPSSYHTP	OR2T4	286	Q8NH00
AMYTYVLPHSYHTPE	OR2T7	246	P0C7T2
HLYFTPRPATRTYSM	PDZD2	2211	O15018
VTHMDNPPYYRITSS	FRYL	1456	O94915
TTPSDYYHQMTLVAG	GLI2	171	P10070
MPPHIYAITDTAYRS	MYH9	146	P35579
MYTYVLPHSYHTPEQ	OR2T27	256	Q8NH04
TQYIRHGSKPMYTPE	PAH	266	P00439
RLPNYATYSHPVTMP	MILR1	201	Q7Z6M3
LSKRTPVFHNYMYAP	SBF1	1561	O95248
YEPGYNSSHPTIVMF	HERC5	926	Q9UII4
AGYAHVLTPYMSSVP	OPN4	321	Q9UHM6
ASDIMEPNLTYVYPH	CLCN6	601	P51797
GPVTVYPYMHALDTL	IGSF8	566	Q969P0
SQQYIPHGYMELTIP	KMO	186	O15229
GLYQTVMSHSFYPPL	DNAH3	71	Q8TD57
YTAMYPTAAITPIAH	CELF5	366	Q8N6W0
PTSLHYMSPYQLSAY	CPNE9	316	Q8IYJ1
YRTYMTHTIFEPTPF	GLB1L	416	Q6UWU2
VAILTATYPVGHMPY	ANKH	276	Q9HCJ1
LPPEMYVYSTNSDHL	ANKMY1	166	Q9P2S6
PLYQDTMGPSQHVYA	CSF3R	506	Q99062
QDTQPHYIYSPREMT	DYNC1H1	2786	Q14204
PFVHTNVPQSMFSYD	FAAH	181	O00519
NYNHLMPTRYSVDIP	RPL27	76	P61353
LTSAPYAMTYAPASA	CRX	186	O43186
FMLHTKYQVVYPFPT	DCAF15	216	Q66K64
RQVMYAPYPTTHIDV	C9orf72	296	Q96LT7
SHMPGTYLTTVIPYE	FEZ2	296	Q9UHY8
VPNSYYPDETHTMAS	PTPRM	836	P28827
IFTYMRPKSYHTPGQ	OR2AJ1	256	Q8NGZ0
PYSLMPNSLAHSNYT	NFE2	181	Q16621
HSTDPSALMYPTYKY	MMP20	236	O60882
THAKPPYSYISLITM	FOXA2	156	Q9Y261
CTGNYTFVPYMITPH	MAP3K5	206	Q99683
ENYKTPGYVVTPHTM	QARS1	236	P47897
FYPNHKEMLSSTTYP	SYN1	251	P17600
LMVYSQGSFPEHYAP	RHOF	36	Q9HBH0
IYQYVLNSMAPHPSR	STARD13	996	Q9Y3M8
PLMYSHPYSQITVET	SEZ6L	991	Q9BYH1
IHPYLSTMINYAQPV	PLCB4	561	Q15147
AAITMVNYYSAVTPH	PTBP2	106	Q9UKA9
PYTEPSMEVFSYHQG	FARSA	411	Q9Y285
TVMVKYTSHYPQPGD	SLC35G2	21	Q8TBE7
VHTPNRTYYLMDPSG	PDPK1	516	O15530
DPINPTYEATNAMYH	PRODH	461	O43272
PEYNLPHTYVEMQSL	SMG9	291	Q9H0W8
KYGYTSQASPHTMPL	ST8SIA2	336	Q92186
PYVGYTVQHDSVPMT	SHISA2	246	Q6UWI4
MSTPNAPLHYYETVR	ST3GAL3	326	Q11203
PPHIFSISDNAYQYM	MYH6	151	P13533
DLQVTMPHSYPYVAL	RWDD2A	71	Q9UIY3
PPHIYAIADTAYRSM	MYH11	151	P35749
MVATPPVTYSHFAQD	ZNF738	101	Q8NE65
HSNDPTAIMAPFYQY	MMP16	256	P51512
SIYHIMATQPGAPSA	PLEKHD1	486	A6NEE1
QAHYLRSPSPSQYSM	STYXL2	26	Q5VZP5
FRHPYPTALTVNASM	TCF7L2	276	Q9NQB0
SPLTQHQSYIPYMHG	ZNF609	1216	O15014
SEAQVAAPTAVYYMP	TEX13C	196	A0A0J9YWL9
THYTLLFTHTYMPPR	PIGZ	456	Q86VD9
AAVTMVNYYTPITPH	PTBP3	106	O95758
SYTSPNVRSLMPHYQ	ZNF462	931	Q96JM2
APEYLPTMSSTDMYH	SLC4A4	646	Q9Y6R1
HVPSYGSVMYTSISQ	HIVEP2	1341	P31629
ASQHITPSYNYAPNM	SULF1	241	Q8IWU6
FVSSYQPMYLTHEPL	TBRG1	376	Q3YBR2
ISPYSNPDRMSHYTI	TGFBR3	641	Q03167
ATYHYPLVAQMPVSS	NACA	421	E9PAV3
SQPEHMKQPRVYTSY	PCSK1	596	P29120